Sally van Kooten

Sally van Kooten is a seasoned professional in the biopharmaceutical industry with extensive experience in commercial strategy and management. Currently serving as the Head of Europe and Vice President of Commercial Strategy at KalVista Pharmaceuticals, Inc. since July 2020, Sally has previously held significant roles at Takeda as Senior Director, Global Commercial Lead for HAE, and at Shire in various director-level positions, including Global Launch Lead for Takhzyro and Global Commercial Lead for Cinryze. Career beginnings included roles at CSL Behring, Shire, RSVP GROUP Leadership Services AG, Sanofi-Synthelabo, and Merck Sharp & Dohme. Sally holds a BSc (hon) in Physiology from the University of St Andrews, a degree in Business Administration from Edinburgh Napier University, and a Mini MBA in Brand Management.